Skip to content

Author

A. Sahebkar

7 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

2026

The effect of curcumin-piperine supplementation on liver transient elastography and biochemical indices in patients with non-alcoholic fatty liver disease: A randomized controlled trial

Objective: Non-alcoholic fatty liver disease (NAFLD), characterized by an excessive buildup of triglycerides in hepatocytes, currently lacks an approved pharmacological treatment. This study investigated the therapeutic potential of a curcumin-piperine supplement, leveraging curcumin's established antioxidant, anti-inf...

S. Rafiee, Mohammad Bagherniya, Ziba Khoram et al. · 0 citations
Review Sep 2026

Overcoming hurdles in nano-phytochemical development: challenges and future directions.

The clinical applications of phytochemicals are limited due to challenges such as poor tissue distribution, low solubility in bodily fluids, low absorption, off-target toxicity, and low efficacy. Advances in nanomedicine have offered opportunities to overcome these limitations by incorporating phytochemicals into vario...

Ali Bazi, Fatemeh Oroojalian, Prashant Kesharwani et al. · 0 citations
Review Open access Oct 2026

Resveratrol in Microplastic- and Nanoplastic-Induced Toxicity: Current Evidence, Mechanistic Insights, and Future Directions.

Microplastic (MP; MPs) and nanoplastic (NP; NPs) pollution poses a growing threat to global health. Their small size and large surface area facilitate ingestion, accumulation, and interactions with biological systems, leading to toxicity through oxidative stress, inflammation, mitochondrial dysfunction, and cell death....

S. Sepahi, H. Mashayekhi-sardoo, Adel Ghorani Azam et al. · 0 citations
Review Open access Jan 2026

Prodrug Strategies in Atherosclerosis: Targeted Delivery and Therapeutic Advances

Key barriers to clinical translation remain, including poor scalability and reproducibility of nanomaterials, patient variability in plaque biology, limited long‐term safety data, and regulatory challenges for complex nanosystems remain.

Elaheh Mirhadi, W. Almahmeed, Prashant Kesharwani et al. · 0 citations
Review Open access Aug 2026

Gold Nano Biosensing Technologies for Early Breast Cancer Diagnosis: Recent Progress and Future Perspectives

Breast cancer remains one of the foremost causes of cancer‐related mortality among women worldwide, where survival outcomes are strongly dictated by the timeliness and precision of diagnosis. In this review, we present gold nanomaterial‐driven biosensors as a transformative frontier in ultrasensitive breast cancer dete...

A. Pawar, Muskan Leharwani, D. Bukhary et al. · 0 citations
Review Sep 2026

Stimuli-Responsive Mesoporous Silica Nanoparticles for Precision Cancer Therapy: Design Principles, Cellular Uptake, and Translational Perspectives.

This review highlights recent progress in the design and application of stimuli-responsive MSNs for cancer therapy, with particular emphasis on mechanisms of intracellular uptake, factors influencing cellular internalization, and strategies for controlled drug release.

U. Abbasi, Md. Saifuddin, Mahak Fatima et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.